Follow Us:

These webcasts are co-provided by the CancerNet and A. Webb Roberts Center for CME of Baylor Scott & White Health.
For more information visit: www.cancernetus.com
![]() |
![]() |
Amgen, Inc.
These webcasts are intended to improve care of patients with multiple myeloma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussions of novel agents at various stages of clinical development will be given significant focus. These Internet CME activities are designed to provide clinical decision-making strategies for integration of novel therapeutic options.
Each module offers:
This webcast is intended to improve care of patients with multiple myeloma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
This webcast is intended to improve care of patients with multiple myeloma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
This webcast is intended to improve care of patients with multiple myeloma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.